Matthew Katz, MD 🟦 (@subatomicdoc) 's Twitter Profile
Matthew Katz, MD 🟦

@subatomicdoc

I'm a cancer doctor @TuftsMedicalCtr dedicated to improving health and cancer care. Trust, learn, collaborate. Neutral good. He/him.

ID: 88581667

linkhttp://www.subatomicdoc.com calendar_today09-11-2009 03:27:46

109,109K Tweet

20,20K Followers

5,5K Following

ESTRO (@estro_rt) 's Twitter Profile Photo

✅@RadOnc_Journal & @TheLancetOncology are teaming up! Submit your clinical trials for a chance to present at a special joint session and get published in one of these top journals. Pierre Blanchard, MD, David Collingridge 📅: 20 Nov 2024 ℹ️ bit.ly/47aASOa #ESTRO25 #radonc

✅@RadOnc_Journal & @TheLancetOncology are teaming up! Submit your clinical trials for a chance to present at a special joint session and get published in one of these top journals.  
<a href="/PBlanchardMD/">Pierre Blanchard, MD</a>,  David Collingridge
📅: 20 Nov 2024
 ℹ️ bit.ly/47aASOa

#ESTRO25 #radonc
Aviva Klompas (@avivaklompas) 's Twitter Profile Photo

Rachel Goldberg-Polin: "Ok sweet boy, go now on your journey. I hope it's as good as the trips you dreamed about because finally, my sweet boy, finally, finally, finally, finally you are free. I will love you and I will miss you every single day for the rest of my life, but

Hen Mazzig (@henmazzig) 's Twitter Profile Photo

It's easy to see where Hersh's compassion came from. On what is easily the worst day of her life, Rachel Goldberg-Polin is thanking everyone for their efforts to bring her son home and hoping his death will act as a catalyst to bring the other hostages home alive. She'd have

Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in Nature Reviews Cancer by Sherene Loi, MD et al not only closes a gap in our up to date understanding of immune microenvironment, but is graphically 🔝 Bravo. Required read. nature.com/articles/s4156…

A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in <a href="/NatureRevCancer/">Nature Reviews Cancer</a> by <a href="/LoiSher/">Sherene Loi, MD</a> et al not only closes a gap in our up to date understanding of immune microenvironment, but is graphically 🔝
Bravo. Required read. 
nature.com/articles/s4156…
Bishal Gyawali (@oncology_bg) 's Twitter Profile Photo

A must-read patient/survivor/advocate perspective shedding light on the need to redefine priorities in cancer care and research. nature.com/articles/s4157… NatureRevClinOncol

Pippa Cosper MD, PhD (@pipcosper) 's Twitter Profile Photo

I retreated to a cabin in the middle of nowhere for this long weekend to brainstorm the future directions of my lab/grants. This has been the most incredible 3 days. Highly recommend.

I retreated to a cabin in the middle of nowhere for this long weekend to brainstorm the future directions of my lab/grants. This has been the most incredible 3 days. Highly recommend.
Matt Spraker (@sprakermdphd) 's Twitter Profile Photo

I look forward to opening/offering this trial. Pretty easy logistics and a pure #RadOnc question. Also a rare and important ask: "are more fractions better?"

Real Doc Speaks (@realdocspeaks) 's Twitter Profile Photo

bostonglobe.com/2024/09/03/met… This Boston Globe article chronicles the surreal tale of the looting of an ailing hospital system by its own CEO. The story begins in February of 2022 when the CEO of Steward Health Care, Dr. Ralph de la Torre, was making a $ 10 Million donation for a

Jelena Lukovic, MD FRCPC MPH (@j_lukovic) 's Twitter Profile Photo

Single fraction RT (8Gy) significantly improves hepatic pain compared with best supportive care and can be considered standard palliative treatment. No increase in toxicity. Laura Dawson CCTG thelancet.com/journals/lanon…

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Retrospective series of short v long course RT in rectal cancer Despite achieving similar rates of complete response (~44%), organ preservation w LC better (2yr 40% v 31%) German AIO18.1 RCT to provide definitive data, but for now LC TNT remains preferred reg for non-op intent

Pippa Cosper MD, PhD (@pipcosper) 's Twitter Profile Photo

Very excited to tell this story with support from NRG! There will be pretty cell pictures in addition to boring tables (boring tables reveal amazing data!)

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Sharing an instructive case. Treated isolated liver met single fx SBRT (40Gy). ctDNA 5 days later increased 80 to 1100!! PET 2 wks after negative (tumor gone), & ctDNA 3 wks later <10. Lesson - if checking ctDNA, wait (at least a few wks?) after SBRT. Have others seen this?

Sharing an instructive case. Treated isolated liver met single fx SBRT (40Gy). ctDNA 5 days later increased 80 to 1100!!

PET 2 wks after negative (tumor gone), &amp; ctDNA 3 wks later &lt;10.

Lesson - if checking ctDNA, wait (at least a few wks?) after SBRT.

Have others seen this?